Clarithromycin inhibits fibroblast migrationKOHYAMA, Tadashi; YAMAUCHI, Yasuhiro; TAKIZAWA, Hajime et al.Respiratory medicine. 2008, Vol 102, Num 12, pp 1769-1776, issn 0954-6111, 8 p.Article

Clarithromycin suspension: Bioequivalence studies on two different strengthsKOYTCHEV, Rossen; OZALP, Yildiz; ERENMEMISOGLU, Aydin et al.Arzneimittel-Forschung. 2004, Vol 54, Num 9A, pp 594-599, issn 0004-4172, 6 p.Article

Corneal pharmacokinetics of topically applied azithromycin and clarithromycinKUEHNE, Jonas J; YU, Anna Lisa T; HOLLAND, Gary N et al.American journal of ophthalmology. 2004, Vol 138, Num 4, pp 547-553, issn 0002-9394, 7 p.Article

The pharmacokinetics of clarithromycin and its 14-OH metaboliteDAVEY, P. G.The Journal of hospital infection. 1991, Vol 19, pp 29-37, issn 0195-6701, SUPAArticle

Silica coatings on clarithromycinBELE, Marjan; DMITRASINOVIC, Dorde; PLANINSEK, Odon et al.International journal of pharmaceutics. 2005, Vol 291, Num 1-2, pp 149-153, issn 0378-5173, 5 p.Conference Paper

Human Saliva-Based Quantitative Monitoring of Clarithromycin by Flow Injection Chemiluminescence Analysis: A Pharmacokinetic StudyXIJUAN TAN; ZHENGHUA SONG.Applied biochemistry and biotechnology. 2014, Vol 172, Num 3, pp 1320-1331, issn 0273-2289, 12 p.Article

The effect of hydroxy metabolites of clarithromycin to the pharmacokinetic parameters, and determination of hydroxy metabolites ratio of clarithromycinUNAL, Durisehvar; FENERCIOGLU, Aysen; OZBAY, Latif et al.European journal of drug metabolism and pharmacokinetics. 2009, Vol 34, Num 1, pp 27-30, issn 0378-7966, 4 p.Article

Antibiotic-induced apoptosis in human activated peripheral lymphocytesKADOTA, Jun-Ichi; MIZUNOE, Syunji; KISHI, Kenji et al.International journal of antimicrobial agents. 2005, Vol 25, Num 3, pp 216-220, issn 0924-8579, 5 p.Article

The in-vitro activity and disc susceptibility testing of clarithromycin and its 14-hydroxy metaboliteLOGAN, M. N; ASHBY, J. P; ANDREWS, J. M et al.Journal of antimicrobial chemotherapy (Print). 1991, Vol 27, Num 2, pp 161-170, issn 0305-7453, 10 p.Article

Place actuelle des macrolides en pathologie infectieuse = Macrolides in antibacterial treatment nowadaysLAMY, F.Louvain médical. 1996, Vol 115, Num 10, pp 705-715, issn 0024-6956Article

Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycinFURUTA, Takahisa; SOYA, Yoshihiro; FUJIOKA, Toshio et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 11, pp 1810-1815, issn 0815-9319, 6 p.Article

Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interactionSIPE, Brooke E; JONES, Ronald J; BOKHART, Gordon H et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 808-811, issn 1060-0280, 4 p.Article

Gene Mutations of 23S rRNA Associated with Clarithromycin Resistance in Helicobacter pylori Strains Isolated from Korean PatientsKIM JUNG MOG; JOO SUNG KIM; KIM, Nayoung et al.Journal of microbiology and biotechnology. 2008, Vol 18, Num 9, pp 1584-1589, issn 1017-7825, 6 p.Article

Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitumNASH, Kevin A; YANSHENG ZHANG; BROWN-ELLIOTT, Barbara A et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 2, pp 170-177, issn 0305-7453, 8 p.Article

Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthmaKOSTADIMA, E; TSIODRAS, S; ALEXOPOULOS, E. I et al.The European respiratory journal. 2004, Vol 23, Num 5, pp 714-717, issn 0903-1936, 4 p.Article

Clarithromycin Induced Psoriasis in a 37-Year Old ManZAÏEM, Ahmed; MEBAZAA, Amel; LAKHOUA, Ghozlane et al.Current drug safety (Print). 2014, Vol 9, Num 1, pp 77-78, issn 1574-8863, 2 p.Article

Kutane Infektionen durch Mycobacterium marinum: Eine Übersicht : Atypische Mykobakteriosen = Infections due to Mycobacterium marinum. A review : Atypical mycobacteriaNENOFF, P; KLAPPE, B.-M; MAYSER, P et al.Der Hautarzt. 2011, Vol 62, Num 4, pp 266-271, issn 0017-8470, 6 p.Article

Optimization of tocol emulsions for the intravenous delivery of clarithromycinJIE LI; SHUFANG NIE; XINGANG YANG et al.International journal of pharmaceutics. 2008, Vol 356, Num 1-2, pp 282-290, issn 0378-5173, 9 p.Article

Severe Hypoglycemia from Clarithromycin-Repaglinide Drug InteractionKHAMAISI, Mogher; LEITERSDORF, Eran.Pharmacotherapy. 2008, Vol 28, Num 5, pp 682-684, issn 0277-0008, 3 p.Article

The effect of hydroxy metabolites of clarithromycin to the pharmacokinetic parameters, and determination of hydroxy metabolites ratio of clarithromycinUNALI, Durisehvar; FENERCIOGLU, Aysen; OZBAY, Latif et al.European journal of drug metabolism and pharmacokinetics. 2008, Vol 33, Num 4, pp 243-246, issn 0378-7966, 4 p.Article

Structure―activity relationships of novel alkylides: 3-0-Arylalkyl clarithromycin derivatives with improved antibacterial activitiesLIANG, Jian-Hua; LI, Xiao-Li; HE WANG et al.European journal of medicinal chemistry. 2012, Vol 49, pp 289-303, issn 0223-5234, 15 p.Article

Outbreak of a cutaneous Mycobacterium marinum infection in Jiangsu Haian, ChinaYUMIAO FENG; HUAISHENG XU; HONGSHENG WANG et al.Diagnostic microbiology and infectious disease. 2011, Vol 71, Num 3, pp 267-272, issn 0732-8893, 6 p.Article

Immunomodulatory therapies for sepsis : unexpected effects with macrolidesGIAMARELLOS-BOURBOULIS, Evangelos J.International journal of antimicrobial agents (Print). 2008, Vol 32, issn 0924-8579, S39-S43, SUP1Conference Paper

Clarithromycin-induced granulomatous tubulointerstitial nephritisVINOD KUMAR AUDIMOOLAM; BHANDARI, Sunil.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 9, pp 2654-2655, issn 0931-0509, 2 p.Article

Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistanceANZUETO, Antonio; NORRIS, Sandra.International journal of antimicrobial agents. 2004, Vol 24, Num 1, pp 1-17, issn 0924-8579, 17 p.Article